🇺🇸 FDA
Patent

US 11293010

Methods of producing modified natural killer cells and methods of use

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 11293010 (Methods of producing modified natural killer cells and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K40/15, A61K40/42